Biology and management of lobular endocervical glandular hyperplasia

AIM: Lobular endocervical glandular hyperplasia (LEGH) is a multicystic proliferative disorder of the uterine cervix. The aim of this review was to clarify the current understanding of this unique tumor. METHOD: This article reviews the chronological progress of research regarding clinico‐pathological and genetic aspects of LEGH and related cervical cystic diseases such as Nabothian cyst and adenocarcinoma of gastric type (GAS), using the literature and data from our institute. We also describe clinical management including preoperative diagnosis and adequate surgical/expectant treatment based on the biological features. RESULTS: Recent studies revealed several unique aspects of LEGH, that is, (i) production of gastric mucin, (ii) symptomatic and histological similarity with minimal deviation adenocarcinoma (MDA), and (iii) frequent association with GAS, including MDA. These findings indicated that LEGH is a gastric metaplasia, as well as pre‐cancerous neoplasia. For the preoperative diagnosis of LEGH, the combination of “cosmos” sign on magnetic resonance imaging, detection of gastric mucin, and lack of nuclear atypia on cytology is important. Cone biopsy is effective for pathological diagnosis. Simple hysterectomy is indicated as surgical treatment for LEGH; however, meticulous follow‐up is also an option, especially for young patients, because the rate of malignant transformation was reported to be 1%–2%. For LEGH patients who selected follow‐up, a worsening cytology and increase in lesion size were important signs of malignant change of LEGH for safe follow‐up. CONCLUSION: Proper understanding of the characteristics of LEGH is important for adequate management.